A Study of GW842166 in Adults With Osteoarthritis Pain

NCT00447486 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 308

Last updated 2009-05-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether GW842166 is effective in the treatment of osteoarthritis pain of the knee.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

GW842166

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials, BSc MB PhD · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30

Countries

  • Denmark
  • Germany
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00447486 on ClinicalTrials.gov